SYRACUSE, N.Y., Nov. 8, 2023 /PRNewswire/ — If the eyes are the windows to the soul, the nose is the foundation of facial symmetry. For the past several years, one of the most sought-after aesthetic procedures has been rhinoplasty with minimal downtime. To change the appearance of their nose, many people have turned to non-surgical rhinoplasty using polydioxanone (PDO) threads. The benefit is a similar result to surgery, without the need for invasive or expensive treatments, or a lengthy recovery period.
Recently, PDO Max® FDA-cleared threads in-cannula were used in a prospective study to demonstrate the positive effects of PDO threads nasal augmentation on patient quality of life (using FACE-Q Scale) and first impression assessment. The result of the study shows that the PDO threads alone can be used safely to achieve minor nasal changes, especially in tip rotation and the appearance of dorsal hump, to improve the perceived attractiveness of treated patients and improve patients’ quality of life.
The cohort study was conducted with 10 adult patients who sought non-surgical rhinoplasty, and the results were published in August 2023 in the Journal of Cosmetic Dermatology. According to the authors, each patient was treated with the appropriate size and number of PDO threads necessary to achieve optimal correction results. Two weeks after treatment, each patient completed post-treatment FACE-Q surveys, and post-treatment photos were obtained and analyzed. First impression surveys were created using pre- and post-treatment photos, and the survey was completed by 146 blinded evaluators.
“We are pleased with the results of the study, and have confidence that absorbable PDO Max threads, when expertly placed in the nose create lifting and improved definition of the nose bridge and nose tip,” says PDO Max founder Giovanna McCarthy. “We are committed to bringing information to our aesthetic medical professionals that aid in the adoption of non-invasive aesthetic procedures using our complete line of FDA-cleared PDO threads, and PDO AfterGlo™ serum, and Glowpin™ micro-infusion stamper.”
About: PDO MAX, Inc. is headquartered in Liverpool, NY, and is a woman-owned medical device provider for medical aesthetic needs in the U.S. PDO Max is the trusted provider of hundreds of medical practices utilizing its proprietary FDA-cleared (K190245) Polydioxanone (PDO) threads- in-cannula. PDO Max offers hands-on individual instructional courses along with e-Learning courses, which cover the application of PDO thread techniques. For more information regarding PDO MAX threads, to place an order, or to schedule a training, please contact PDO Max at 800-670-0225 or visit https://www.pdomax.com.
Non-surgical rhinoplasty using polydioxanone threads
Omotara Sulyman MD, Robert Cristel MD, Nimit Gandhi MD, Eljona Kola MS, Selika Gutierrez Borst MS, RN, Benjamin Caughlin MD, Steven Dayan MD
First published: 04 August 2023 https://doi.org/10.1111/jocd.15894
SOURCE PDO Max